Yes, there is a patient assistance program available for Kadcyla treatment. Kadcyla is a medication used for the treatment of certain types of breast cancer. The drug is manufactured by Genentech, a subsidiary of Roche. The patient assistance program is designed to provide financial support and assistance options to eligible patients who are prescribed Kadcyla.

According to the official Kadcyla website, there are several assistance options available for patients. These options include co-pay assistance programs, which can help reduce out-of-pocket costs for eligible patients. The website also mentions that Genentech Access Solutions can help patients navigate insurance coverage and provide information on financial assistance programs [2].

Additionally, the Drug Patent Watch website confirms that Kadcyla has a patient assistance program available. The program aims to assist eligible patients who are prescribed Kadcyla by providing financial support and resources to help with the cost of the medication [1].

It is important to note that eligibility criteria and specific details of the patient assistance program may vary. Patients are advised to consult with their healthcare provider or contact Genentech Access Solutions for more information on how to access the program and determine their eligibility [2].

In conclusion, there is a patient assistance program available for Kadcyla treatment. This program offers financial support and assistance options to eligible patients prescribed Kadcyla. Patients are encouraged to consult with their healthcare provider or contact Genentech Access Solutions for more information on how to access the program and determine their eligibility.

Sources:
[1] Drug Patent Watch: Kadcyla - Patient Assistance Program. Retrieved from https://www.drugpatentwatch.com/p/biologics/tradename/KADCYLA
[2] Kadcyla: Financial Support - Assistance Options. Retrieved from https://www.kadcyla.com/early-breast-cancer/financial-support/assistance-options.html